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Uterine rupture is an uncommon, but a life-threatening, complication following second trimester medical termination of
pregnancy (TOP). The reported cases have been in both the scarred and unscarred uterus (Rajesh et al. 2002, Drey et al. 2006,
and Dickinson). A 27-year-old with two previous deliveries, no previous caesarean section, no history of induced abortions, and
no gynaecological operations. She presented with amenorrhoea, and according to her last normalmenstruation, she was 10 weeks
and 5 days. Ultrasound was done, and it reported 16 weeks and 5 days. She asked for TOP. According to the clinic’s protocol,
misoprostol 800mcg (4 tabs) were given to be used vaginally as a loading dose and another three to be taken orally after that. In
the following day when she attended the clinic for follow up, a manual vacuum aspiration (MVA). A manual vacuum aspiration
was indicated as an incomplete abortion. During the procedure, a uterine rupture was found in the uterine lower segment. A
laparotomy was done and a lineal uterine rupture was found and sutured. The patient had a good postoperative recovery and
was discharged from hospital after four days. The clinician dealing with second trimester terminations should be aware of the
possibility of having a uterine rupture, especially in patients with a uterine scar in order to make an early diagnosis.
1.Introduction
Uterine rupture is an uncommon, but a life-threatening
complication following second trimester medical termina-
tion of pregnancy (TOP). The reported cases have been in
boththe scarred and unscarred uterus[1–3]. The occurrence
is about 0.2% in the intact uterus and 3.8 to 4.3% in the
scarred uterus [1, 2].
2.CaseReport
A 27 year-old woman with two previous deliveries, no
history of previous caesarean section, no induced abortions,
and no gynaecological operations, presented with amen-
orrhoea seeking for TOP in her third pregnancy. She had
no pregnancy symptoms and no history of contraceptive
use. According to her last normal menstrual period, her
gestational age was ten weeks and six days.
On physical examination, blood pressure was 110/70,
and pulse was 76 beats per minute. Symphisis fundal height
was 15cm. An ultrasound scan was done. It reported 16
weeks and 5 days (Biparietal diameter, femur length, and
abdominal circumference).
Thepatientwascounselledfortermination ofpregnancy;
t h em e t h o d s ,s i d ee ﬀects, and complications were explained.
Alternative options were also discussed. She opted for TOP.
Based on the Choice of Termination of Pregnancy Act,
1996 (CTOP, Act 1996), her request was accepted. According
to the clinic’s protocol, seven misoprostol tablets (Cytotec
200mcg) were issued to the patient with the full instructions
on how to be used at home. Four tablets (800mcg) to be
inserted deep in vagina as a loading dose. Three hours later
she was instructed to use one tablet every 2 hours orally for
three doses.
She inserted the tablets at 22:00 that night. She aborted
at 07:00 the following morning while she was coming to the
clinic for follow up.
On examination, a contracted, not tender uterus, 6cm
above the pelvis brim, was found, as well as a soft abdo-
men. On vaginal examination, she presented with a minor2 Obstetrics and Gynecology International
bleeding and an opened cervix. A manual vacuumaspiration
indicated that she had an incomplete abortion. During the
introduction of the cannulae, a uterine rupture was di-
agnosed in the lower segment. The Hb at that stage was
7.6g/dL. Two units of blood were ordered.The patient was
prepared and booked for theatre immediately for an explor-
atory laparotomy. During the operation, 50mL of blood
was found in the abdomen with a linear rupture of 6cm
in the lower segment of the uterus. This was sutured in
one layer, covering with the visceral peritoneum with-
out complications. The patient was given antibiotics as per
protocol (Amoxicillin and Methronidazole) and had a good
postoperative recovery. She was discharged four days later.
3.Discussion
Medical abortion was started in the late eighties, becoming
more widely used in the late nineties with the mifepristone
and misoprostol being the most used. It came as an
alternative for the dilation and curettage which caused more
complications, resulting in 50,000–100,000 maternal deaths
every year [4, 5].
Misoprostol alone for termination of pregnancy (TOP)
was described for the ﬁrst time in 1994. It has been
used widely for TOP in the normal uterus [4, 5]. Other
prostaglandins (gemeprost, sulprostone) have been used
but those are more expensive and have not been used
widely. Methotrexate has also been used, but the gynaecol-
ogists are not comfortable with it due to its teratogenic-
ity. Extra-amniotic methods were used with prostaglandin
instilled through an intracervical catheter [3]. Mifepristone
prostaglandin has been shown to be safe and eﬀective, with
a success rate of 92–96% [6, 7]. Misoprostol has been used
for TOP in diﬀerent ways, vaginal, oral, and in combination
of the two routes in the ﬁrst and second trimester [8]. The
mortality and morbidity of the second trimester is greater
than that of the ﬁrst trimester termination. Abortion-related
morbidity and mortality increase signiﬁcantly as pregnancy
a d v a n c e sw i t has h a r pr i s ei nt h er a t eo fs e v e r ec o m p l i c a t i o n s
in induced abortion after 14 weeks of pregnancy [9, 10].
Women present with varying reasons for the delay in
presenting, being logistical, social, or economic. Uterine
rupture with the use of misoprostol has been reported
more frequently in multiparous women and in women with
uterine scars. It is more often observed at term than in the
second trimester [3]. The rate of caesarean births has been
on the rise, it has lead to and increasing numbers of women
with a uterine scar seeking TOP [3–7]. The Reproductive
Health Clinic at National District Hospital in Bloemfontein
has been working for more than a decade dealing with
termination of pregnancy. During that period, misoprostol
alone has been used, combining the vaginal and oral route
(800mcg vaginally as a loading dose and 600mcg orally in
three divided doses) with a high success rate and no known
previous complication. The clinician dealing with second
trimester terminations should be aware of the possibility of
having a uterine rupture, especially in patients with a uterine
scar in order to make an early diagnosis.
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